Geulah Livshits
Stock Analyst at Chardan Capital
(4.05)
# 1,611
Out of 4,382 analysts
653
Total ratings
35%
Success rate
6.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Reiterated: Buy | $240 | $108.67 | +120.85% | 12 | May 20, 2026 | |
| IMTX Immatics | Reiterated: Buy | $25 | $9.79 | +155.36% | 22 | May 19, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $20 | $4.27 | +368.38% | 15 | May 19, 2026 | |
| SNTI Senti Biosciences Holdings | Reiterated: Buy | $13 → $12 | $0.9654 | +1,143.01% | 12 | May 15, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $8 | $0.7281 | +998.75% | 21 | May 15, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $15 | $6.70 | +123.88% | 12 | May 13, 2026 | |
| MGX Metagenomi Therapeutics | Reiterated: Buy | $7 | $1.29 | +444.75% | 7 | May 13, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $17 | $4.37 | +289.02% | 13 | May 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $11 | $2.75 | +300.00% | 39 | May 10, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $26 | $8.64 | +200.93% | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.06 | +194.12% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $4.23 | +230.97% | 53 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.50 | +118.18% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $4 | $2.71 | +47.60% | 43 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $10.55 | +108.53% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $51.84 | +46.60% | 57 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $301.00 | +7.31% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $30 | $13.54 | +121.57% | 51 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $21 | $5.62 | +273.67% | 17 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $47.44 | - | 41 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €1.00 | $0.3775 | +164.90% | 8 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7 | $2.13 | n/a | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.25 | n/a | 23 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $36 | $9.00 | n/a | 18 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $26.45 | n/a | 6 | Aug 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.25 | n/a | 11 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.02 | n/a | 12 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.29 | n/a | 3 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $8.53 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €15.00 | $0.0837 | n/a | 7 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $76 | $6.08 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $6 | $3.33 | n/a | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $15 | $13.11 | n/a | 10 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $31.11 | n/a | 3 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.0127 | n/a | 5 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $18.58 | n/a | 2 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 17 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $48 | $9.47 | n/a | 9 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $2.39 | n/a | 1 | Jun 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $16.53 | n/a | 10 | Feb 20, 2020 |
Palvella Therapeutics
May 20, 2026
Reiterated: Buy
Price Target: $240
Current: $108.67
Upside: +120.85%
Immatics
May 19, 2026
Reiterated: Buy
Price Target: $25
Current: $9.79
Upside: +155.36%
Immuneering
May 19, 2026
Reiterated: Buy
Price Target: $20
Current: $4.27
Upside: +368.38%
Senti Biosciences Holdings
May 15, 2026
Reiterated: Buy
Price Target: $13 → $12
Current: $0.9654
Upside: +1,143.01%
Tenaya Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $0.7281
Upside: +998.75%
Solid Biosciences
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $6.70
Upside: +123.88%
Metagenomi Therapeutics
May 13, 2026
Reiterated: Buy
Price Target: $7
Current: $1.29
Upside: +444.75%
Lexeo Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $17
Current: $4.37
Upside: +289.02%
Rocket Pharmaceuticals
May 10, 2026
Reiterated: Buy
Price Target: $11
Current: $2.75
Upside: +300.00%
4D Molecular Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $26
Current: $8.64
Upside: +200.93%
May 8, 2026
Reiterated: Buy
Price Target: $9
Current: $3.06
Upside: +194.12%
May 7, 2026
Reiterated: Buy
Price Target: $16 → $14
Current: $4.23
Upside: +230.97%
May 6, 2026
Reiterated: Buy
Price Target: $12
Current: $5.50
Upside: +118.18%
May 5, 2026
Reiterated: Buy
Price Target: $3.5 → $4
Current: $2.71
Upside: +47.60%
May 5, 2026
Maintained: Buy
Price Target: $22
Current: $10.55
Upside: +108.53%
May 4, 2026
Reiterated: Buy
Price Target: $76
Current: $51.84
Upside: +46.60%
May 4, 2026
Reiterated: Buy
Price Target: $323
Current: $301.00
Upside: +7.31%
Apr 27, 2026
Maintained: Buy
Price Target: $27 → $30
Current: $13.54
Upside: +121.57%
Nov 12, 2025
Maintained: Buy
Price Target: $120 → $21
Current: $5.62
Upside: +273.67%
Oct 7, 2025
Rated: Hold
Price Target: n/a
Current: $47.44
Upside: -
Sep 17, 2025
Maintained: Buy
Price Target: €1.00
Current: $0.3775
Upside: +164.90%
Mar 24, 2025
Maintained: Buy
Price Target: $11 → $7
Current: $2.13
Upside: n/a
Jan 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.25
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $41 → $36
Current: $9.00
Upside: n/a
Aug 25, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $26.45
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $12
Current: $3.25
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $1.02
Upside: n/a
Jan 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.29
Upside: n/a
Dec 14, 2022
Maintained: Buy
Price Target: $11
Current: $8.53
Upside: n/a
Jul 28, 2022
Reiterated: Buy
Price Target: €15.00
Current: $0.0837
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $90 → $76
Current: $6.08
Upside: n/a
Mar 9, 2022
Reiterated: Hold
Price Target: $4 → $6
Current: $3.33
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: $25 → $15
Current: $13.11
Upside: n/a
Jan 5, 2022
Reiterated: Buy
Price Target: $22 → $20
Current: $31.11
Upside: n/a
Dec 17, 2021
Reiterated: Buy
Price Target: $30
Current: $0.0127
Upside: n/a
Aug 20, 2021
Reiterated: Buy
Price Target: $18 → $21
Current: $18.58
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 14, 2020
Maintained: Buy
Price Target: $30 → $48
Current: $9.47
Upside: n/a
Jun 4, 2020
Initiated Coverage: Buy
Price Target: $28
Current: $2.39
Upside: n/a
Feb 20, 2020
Reiterated: Hold
Price Target: $1
Current: $16.53
Upside: n/a